Clinicians use it in the prevention and treatment of macrocytic anemia associated with vitamin B12 deficiency
A CoA documents the exact compound tested, its purity, and batch identifiers
A mechanistic study published in 2025 traced these changes substantially to a glucagon-driven reduction in a liver protein complex (ANGPTL3/8) that controls how the bloodstream clears triglycerides, a pathway most other cholesterol drugs do not target directly [10]
Hashimoto thyroiditis Hashimoto thyroiditis, the most common autoimmune condition globally, involves immune-mediated destruction of thyroid tissue
Side effects, when they occur, tend to be mild and dose related, such as injection site irritation or temporary water retention
Included in the FDA Inactive Ingredients Database (dental preparations